|
1
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kohli A, Shaffer A, Sherman A and Kottilil
S: Treatment of hepatitis C: A systematic review. JAMA.
312:631–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lim KC, Chow PK, Allen JC, Siddiqui FJ,
Chan ES and Tan SB: Systematic review of outcomes of liver
resection for early hepatocellular carcinoma within the Milan
criteria. Br J Surg. 99:1622–1629. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thelen A, Benckert C, Tautenhahn HM, Hau
HM, Bartels M, Linnemann J, Bertolini J, Moche M, Wittekind C and
Jonas S: Liver resection for hepatocellular carcinoma in patients
without cirrhosis. Br J Surg. 100:130–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Springer TA: Adhesion receptors of the
immune system. Nature. 346:425–434. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smith ME and Thomas JA: Cellular
expression of lymphocyte function associated antigens and the
intercellular adhesion molecule-1 in normal tissue. J Clin Pathol.
43:893–900. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maio M, Pinto A, Carbone A, Zagonel V,
Gloghini A, Marotta G, Cirillo D, Colombatti A, Ferrara F, Del
Vecchio L, et al: Differential expression of CD54/intercellular
adhesion molecule-1 in myeloid leukemias and in lymphoproliferative
disorders. Blood. 76:783–790. 1990.PubMed/NCBI
|
|
9
|
Natali P, Nicotra MR, Cavaliere R, Bigotti
A, Romano G, Temponi M and Ferrone S: Differential expression of
intercellular adhesion molecule 1 in primary and metastatic
melanoma lesions. Cancer Res. 50:1271–1278. 1990.PubMed/NCBI
|
|
10
|
Vánky F, Wang P, Patarroyo M and Klein E:
Expression of the adhesion molecule ICAM-1 and major
histocompatibility complex class I antigens on human tumor cells is
required for their interaction with autologous lymphocytes in
vitro. Cancer Immunol Immunother. 31:19–27. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Diamond MS, Staunton DE, de Fougerolles
AR, Stacker SA, Garcia-Aguilar J, Hibbs ML and Springer TA: ICAM-1
(CD54): A counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol.
111:3129–3139. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carlos TM and Harlan JM:
Leukocyte-endothelial adhesion molecules. Blood. 84:2068–2101.
1994.PubMed/NCBI
|
|
13
|
Sallusto F and Lanzavecchia A: Efficient
presentation of soluble antigen by cultured human dendritic cells
is maintained by granulocyte/macrophage colony-stimulating factor
plus interleukin 4 and downregulated by tumor necrosis factor
alpha. J Exp Med. 179:1109–1118. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen J, Devery JM and King NJ: Adherence
status regulates the primary cellular activation responses to the
flavivirus West Nile. Immunology. 84:254–264. 1995.PubMed/NCBI
|
|
15
|
Gho YS, Kleinman HK and Sosne G:
Angiogenic activity of human soluble intercellular adhesion
molecule-1. Cancer Res. 59:5128–5132. 1999.PubMed/NCBI
|
|
16
|
Wittekind C: Hepatobiliary sectionTNM
Classification of Malignant Tumours. 8th. Brierley JD,
Gospodarowicz MK and Wittekind C: Wiley; West Sussex: pp. 80–82.
2017
|
|
17
|
Bedossa P and Poynard T: An algorithm for
the grading of activity in chronic hepatitis C. The METAVIR
Cooperative Study Group. Hepatology. 24:289–293. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Momosaki S, Yano H, Ogasawara S, Higaki K,
Hisaka T and Kojiro M: Expression of intercellular adhesion
molecule 1 in human hepatocellular carcinoma. Hepatology.
22:1708–1713. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu S, Li N, Yu X, Xiao X, Cheng K, Hu J,
Wang J, Zhang D, Cheng S and Liu S: Expression of intercellular
adhesion molecule 1 by hepatocellular carcinoma stem cells and
circulating tumor cells. Gastroenterology. 144:1031–1041. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shimizu Y, Minemura M, Tsukishiro T,
Kashii Y, Miyamoto M, Nishimori H, Higuchi K and Watanabe A: Serum
concentration of intercellular adhesion molecule-1 in patients with
hepatocellular carcinoma is a marker of the disease progression and
prognosis. Hepatology. 22:525–531. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu PP, Yuan SG, Liao Y, Qin LL and Liao
WJ: High level of intercellular adhesion molecule-1 affects
prognosis of patients with hepatocellular carcinoma. World J
Gastroenterol. 21:7254–7263. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Harning R, Mainolfi E, Bystryn JC, Henn M,
Merluzzi VJ and Rothlein R: Serum levels of circulating
intercellular adhesion molecule 1 in human malignant melanoma.
Cancer Res. 51:5003–5005. 1991.PubMed/NCBI
|
|
23
|
Grothey A, Heistermann P, Philippou S and
Voigtmann R: Serum levels of soluble intercellular adhesion
molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung
cancer: Correlation with histological expression of ICAM-1 and
tumour stage. Br J Cancer. 77:801–807. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang GJ and Adachi I: Serum levels of
soluble intercellular adhesion molecule-1 and E-selectin in
metastatic breast carcinoma: Correlations with clinicopathological
features and prognosis. Int J Oncol. 14:71–77. 1999.PubMed/NCBI
|
|
25
|
Kitagawa T, Matsumoto K and Iriyama K:
Serum cell adhesion molecules in patients with colorectal cancer.
Surg Today. 28:262–267. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Benekli M, Güllü IH, Tekuzman G, Savaş MC,
Hayran M, Hasçelik G and Firat D: Circulating intercellular
adhesion molecule-1 and E-selectin levels in gastric cancer. Br J
Cancer. 78:267–271. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Becker JC, Termeer C, Schmidt RE and
Bröcker EB: Soluble intercellular adhesion molecule-1 inhibits
MHC-restricted specific T cell/tumor interaction. J Immunol.
151:7224–7232. 1993.PubMed/NCBI
|
|
28
|
Shimura T, Shibata M, Gonda K, Kofunato Y,
Okada R, Ishigame T, Kimura T, Kenjo A, Marubashi S, Kono K and
Takenoshita S: Clinical significance of soluble intercellular
adhesion molecule-1 and interleukin-6 in patients with extrahepatic
cholangiocarcinoma. J Invest Surg. Sep 19–2017.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Altomonte M, Colizzi F, Esposito G and
Maio M: Circulating intercellular adhesion molecule 1 as a marker
of disease progression in cutaneous melanoma. N Engl J Med.
327:9591992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Spiekerman AM: Nutritional assessment
(protein nutriture). Anal Chem. 67:429R–436R. 1995. View Article : Google Scholar : PubMed/NCBI
|
